Long Non-Coding RNA HNF1A-AS1 Promotes Proliferation and Suppresses Apoptosis of Bladder Cancer Cells Through Upregulating Bcl-2.

Yonghao Zhan,Yifan Li,Bao Guan,Zicheng Wang,Ding Peng,Zhicong Chen,Anbang He,Shiming He,Yanqing Gong,Xuesong Li,Liqun Zhou
DOI: https://doi.org/10.18632/oncotarget.20795
2017-01-01
Oncotarget
Abstract:Emerging evidences have indicated that long non-coding RNAs (lncRNAs) are pivotal regulators of tumor development and progression. HNF1A-AS1 (HNF1A antisense RNA 1, C12 or f27) is a novel long non-coding RNA that acts as a potential biomarker and is involved in development and progression of several cancers. Nevertheless, we know nothing about the clinical significance and molecular mechanism of HNF1A-AS1 in bladder cancer. In this study, we found that HNF1A-AS1 is significantly up-regulated in bladder cancer. Further experiments had demonstrated that silencing HNF1A-AS1 in bladder cancer cells could inhibit the proliferation and induce apoptosis. Mechanistically, we found down-regulated of HNF1A-AS1 increased the expression of miR-30b-5p and subsequently inhibited the expression of Bcl-2, in a ceRNA-dependent way. Moreover, knockdown of miR-30b-5p reversed cell proliferation inhibition and cell apoptosis induced by silencing HNF1A-AS1. In conclusions, we demonstrated that HNF1A-AS1 plays an important regulatory role in bladder cancer and shed new light on lncRNA-directed diagnostic and therapeutics in bladder cancer.
What problem does this paper attempt to address?